1. Home
  2. POM vs BFRI Comparison

POM vs BFRI Comparison

Compare POM & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

POM

POMDOCTOR LIMITED American Depositary Shares

N/A

Current Price

$0.11

Market Cap

13.5M

ML Signal

N/A

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.80

Market Cap

13.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POM
BFRI
Founded
2015
1997
Country
China
United States
Employees
N/A
94
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
13.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
POM
BFRI
Price
$0.11
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.75
AVG Volume (30 Days)
18.6M
202.8K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.36
Revenue Next Year
N/A
$16.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.54
52 Week High
$6.43
$1.19

Technical Indicators

Market Signals
Indicator
POM
BFRI
Relative Strength Index (RSI) 36.39 31.13
Support Level $0.06 $0.77
Resistance Level $0.43 $0.94
Average True Range (ATR) 0.09 0.08
MACD -0.01 -0.03
Stochastic Oscillator 8.36 14.06

Price Performance

Historical Comparison
POM
BFRI

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Share on Social Networks: